cannabis indica

Índice completo — página 53 de 77

Estudos 5.201 a 5.300 de 7.640, ordenados do mais recente ao mais antigo — nesta página, publicações de 2016. Para buscar por termo ou combinar filtros, use o acervo com busca.

Estudos 5.201 a 5.300

  1. 2016

    Cannabidiol Rather Than Cannabis Sativa Extracts Inhibit Cell Growth And Induce Apoptosis In Cervical Cancer Cells

    FavorávelEstudo LaboratorialCâncerCâncer — Colo do Útero
  2. 2016

    Cannabidiol, neuroprotection and neuropsychiatric disorders.

    FavorávelMetanáliseInflamaçãoAnsiedadeDoenças Cardiovasculares (DCV)+9
  3. 2016

    Cannabidiol: a potential treatment for post Ebola Syndrome?

    FavorávelMetanáliseDoença pelo Vírus Ebola
  4. 2016

    Cannabidivarin for HIV-Associated Neuropathic Pain: A Randomized, Blinded, Controlled Clinical Trial

    InconclusivoEnsaio Clínico Duplo-CegoDorDor — Neuropatia PeriféricaHIV/AIDSCanabidivarina (CBDV)
  5. 2016

    Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats

  6. 2016

    Cannabinoid hyperemesis syndrome

    DesfavorávelMetanáliseSíndrome da Hiperêmese CanabinoideTetraidrocanabinol (THC)
  7. 2016

    Cannabinoid hyperemesis syndrome masquerading as an eating disorder

  8. 2016

    Cannabinoid Hyperemesis Syndrome: A Case Report of Cyclic Severe Hyperemesis and Abdominal Pain with Long-Term Cannabis Use

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  9. 2016

    Cannabinoid hyperemesis syndrome: A review of the literature

    InconclusivoMetanáliseSíndrome da Hiperêmese Canabinoide
  10. 2016

    Cannabinoid Hyperemesis Syndrome: An Emerging Drug-Induced Disease

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  11. 2016

    Cannabinoid hyperemesis syndrome. A report of six new cases and a summary of previous reports

    InconclusivoMetanáliseSíndrome da Hiperêmese Canabinoide
  12. 2016

    Cannabinoid receptor-specific mechanisms to alleviate pain in sickle cell anemia via inhibition of mast cell activation and neurogenic inflammation.

    FavorávelEstudo em AnimaisDoença FalciformeAnandamida (AEA)Canabinoides Sintéticos JWH-x+1
  13. 2016

    Cannabinoid Receptors Are Overexpressed in CLL but of Limited Potential for Therapeutic Exploitation

    InconclusivoEstudo LaboratorialCâncerCâncer — LeucemiaAnandamida (AEA)Canabinoides Sintéticos AM-x+1
  14. 2016

    Cannabinoid receptors in the kidney

    FavorávelMetanáliseInsuficiência Renal
  15. 2016

    Cannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson's Disease

  16. 2016

    Cannabinoid-dopamine interactions in the physiology and physiopathology of the basal ganglia.

  17. 2016

    Cannabinoids and autoimmune diseases: A systematic review

    FavorávelMetanáliseInflamaçãoEsclerose MúltiplaDiabetes+1
  18. 2016

    Cannabinoids As Potential Treatment for Chemotherapy-Induced Nausea and Vomiting.

  19. 2016

    Cannabinoids for fibromyalgia

    InconclusivoMetanáliseFibromialgiaTHC Farmacêutico
  20. 2016

    Cannabinoids for Symptom Management and Cancer Therapy: The Evidence.

  21. 2016

    Cannabinoids for Treatment of Glaucoma

    InconclusivoMetanáliseGlaucoma
  22. 2016

    Cannabinoids in Palliative Care: Systematic Review and Meta-Analysis of Efficacy, Tolerability and Safety

    InconclusivoMetanálise ClínicaDorCâncerInsônia e Distúrbios do Sono+5
  23. 2016

    Cannabinoids synergize with carfilzomib, reducing multiple myeloma cells viability and migration.

  24. 2016

    Cannabinoids to treat spinal cord injury

    FavorávelMetanáliseLesões da Medula Espinhal
  25. 2016

    Cannabinoids, cannabinoid receptors and tinnitus

    DesfavorávelMetanáliseZumbidoAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+1
  26. 2016

    Cannabinoids, Inflammation, and Fibrosis

  27. 2016

    Cannabis - the Israeli perspective

  28. 2016

    Cannabis and cocaine decrease cognitive impulse control and functional corticostriatal connectivity in drug users with low activity DBH genotypes

  29. 2016

    Cannabis and Psychosis: a Critical Overview of the Relationship.

    FavorávelMetanálisePsicoseEsquizofrenia
  30. 2016

    Cannabis for Refractory Psoriasis-High Hopes for a Novel Treatment and a Literature Review

    FavorávelMetanálisePsoríase
  31. 2016

    Cannabis Hyperemesis Syndrome in the Emergency Department: How Can a Specialized Addiction Team Be Useful? A Pilot Study

    InconclusivoMetanáliseSíndrome da Hiperêmese Canabinoide
  32. 2016

    Cannabis induced asystole

    DesfavorávelMetanáliseEfeitos Adversos da CannabisDoenças Cardiovasculares (DCV)Infarto+1
  33. 2016

    Cannabis--Position Paper of the German Respiratory Society

    FavorávelMetanáliseCâncerEfeitos Adversos da CannabisCâncer — Pulmão+2
  34. 2016

    Cannabis-induced Moto-Cognitive Dysfunction in Wistar Rats: Ameliorative Efficacy of Nigella Sativa

    FavorávelEstudo em AnimaisDisfunção Cognitiva
  35. 2016

    Case Report of Intractable Vomiting and Abdominal Pain Related to Heavy Daily Cannabis Use

    DesfavorávelMetanáliseSíndrome da Hiperêmese CanabinoideTetraidrocanabinol (THC)
  36. 2016

    CB1 Cannabinoid Receptors Mediate Cognitive Deficits And Structural Plasticity Changes During Nicotine Withdrawal

  37. 2016

    CBD-enriched medical cannabis for intractable pediatric epilepsy: The current Israeli experience

    FavorávelMetanáliseEpilepsia
  38. 2016

    Characterization of non-olfactory GPCRs in human sperm with a focus on GPR18.

    FavorávelEstudo LaboratorialInfertilidade MasculinaOutros Compostos Relacionados
  39. 2016

    Chemical Characterization and Trypanocidal, Leishmanicidal and Cytotoxicity Potential of Lantana camara L. (Verbenaceae) Essential Oil.

    FavorávelEstudo LaboratorialLeishmanioseDoença de Chagas
  40. 2016

    Chemical characterization of essential oil from seeds of wild and cultivated carrots from Serbia

    FavorávelEstudo LaboratorialDorCâncerInflamação+2
  41. 2016

    Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes

  42. 2016

    Clinical trials of medicinal cannabis for appetite-related symptoms from advanced cancer: a survey of preferences, attitudes and beliefs among patients willing to consider participation

    FavorávelMetanáliseCâncerAnorexia (perda de apetite)Perda de Apetite
  43. 2016

    Comparing the effects of endogenous and synthetic cannabinoid receptor agonists on survival of gastric cancer cells.

    FavorávelEstudo LaboratorialCâncerCâncer — EstômagoAnandamida (AEA)Outros Compostos Relacionados+1
  44. 2016

    Comparisons of Δ9-Tetrahydrocannabinol and Anandamide on a Battery of Cognition-Related Behavior in Nonhuman Primates

    FavorávelEstudo em AnimaisDisfunção CognitivaAnandamida (AEA)Tetraidrocanabinol (THC)
  45. 2016

    Curcumin and hemopressin treatment attenuates cholestasis-induced liver fibrosis in rats: role of CB1 receptors

    FavorávelEstudo em AnimaisFibroseFibrose — Hepática (Cirrose)Cúrcuma
  46. 2016

    Cyclic vomiting and abdominal pain from prolonged cannabis use

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  47. 2016

    Damaging Effects of Cannabis Use on the Lungs

    DesfavorávelMetanáliseCâncerEfeitos Adversos da CannabisCâncer — Pulmão+2
  48. 2016

    Decreased Expression of Fatty Acid Amide Hydrolase in Women With Polycystic Ovary Syndrome

  49. 2016

    Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine Model

    FavorávelEstudo em AnimaisDoença de AlzheimerDemência
  50. 2016

    Dietary Omega-6/Omega-3 and Endocannabinoids: Implications for Brain Health and Diseases

  51. 2016

    Differential effectiveness of selected non-psychotropic phytocannabinoids on human sebocyte functions implicates their introduction in dry/seborrhoeic skin and acne treatment.

    FavorávelEstudo LaboratorialAcneAnandamida (AEA)
  52. 2016

    Differential effects of endogenous, phyto and synthetic cannabinoids on thrombogenesis and platelet activity

  53. 2016

    Dihydroceramide Accumulation Mediates Cytotoxic Autophagy Of Cancer Cells Via Autolysosome Destabilization

    FavorávelEstudo em AnimaisCâncerCâncer — CérebroTetraidrocanabinol (THC)
  54. 2016

    Distinctive effects of eicosapentaenoic and docosahexaenoic acids in regulating neural stem cell fate are mediated via endocannabinoid signalling pathways

    InconclusivoEstudo em AnimaisDoenças NeurodegenerativasAVC2-Araquidonoilglicerol (2-AG)Ômega-3
  55. 2016

    Do cannabinoids have a role to play in Tourette’s syndrome?

    InconclusivoMetanáliseTiques e Síndrome de Tourette
  56. 2016

    Does cannabis use moderate smoking cessation outcomes in treatment-seeking tobacco smokers? Analysis from a large multi-center trial

    InconclusivoEnsaio Clínico Duplo-CegoDependência QuímicaEfeitos Adversos da CannabisDependência — Cannabis+1
  57. 2016

    Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial

  58. 2016

    Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics

  59. 2016

    Dronabinol has preferential antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns.

    FavorávelEstudo LaboratorialCâncerCâncer — LeucemiaTHC Farmacêutico
  60. 2016

    Dronabinol increases pain threshold in patients with functional chest pain: a pilot double-blind placebo-controlled trial

    FavorávelEnsaio Clínico Duplo-CegoDorAnsiedadeDepressãoTetraidrocanabinol (THC)THC Farmacêutico+3
  61. 2016

    Effect of cannabis on glutamate signalling in the brain: A systematic review of human and animal evidence

    DesfavorávelMetanálisePsicose
  62. 2016

    Effect of cannabis smoking on lung function and respiratory symptoms: a structured literature review

    DesfavorávelMetanáliseCâncerCâncer — PulmãoDPOC+2
  63. 2016

    Effect of marijuana on Essential Tremor: A case report

    FavorávelMetanáliseTremor EssencialTetraidrocanabinol (THC)
  64. 2016

    Effect of Treatment With Geraniol on Ovalbumin-Induced Allergic Asthma in Mice

    FavorávelEstudo em AnimaisAsma
  65. 2016

    Effective treatment of spasticity using dronabinol in pediatric palliative care.

  66. 2016

    Effectiveness Of Cannabidiol Oil For Pediatric Anxiety And Insomnia As Part Of Posttraumatic Stress Disorder: A Case Report

    FavorávelMetanáliseAnsiedadeInsônia e Distúrbios do SonoTEPT
  67. 2016

    Effects of Cannabidiol and Hypothermia on Short-Term Brain Damage in New-Born Piglets after Acute Hypoxia-Ischemia.

  68. 2016

    Effects of cannabinoid receptor activation by CP55,940 on normal bladder function and irritation-induced bladder overactivity in non-awake anaesthetised rats

    FavorávelEstudo em AnimaisInfecção UrináriaCanabinoides Sintéticos CP-x
  69. 2016

    Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings

  70. 2016

    Effects of Medical Marijuana on Migraine Headache Frequency in an Adult Population.

    FavorávelMetanáliseEnxaqueca
  71. 2016

    Effects of Tangshen Formula on urinary and plasma liver-type fatty acid binding protein levels in patients with type 2 diabetic kidney disease: post-hoc findings from a multi-center, randomized, double-blind, placebo-controlled trial investigating the efficacy and safety of Tangshen Formula in patients with type 2 diabetic kidney disease

  72. 2016

    Effects of tetrahydrocannabinol on balance and gait in patients with dementia: A randomised controlled crossover trial

    FavorávelEnsaio Clínico Duplo-CegoDemênciaCondições Geriátricas
  73. 2016

    Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users

  74. 2016

    Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study.

    FavorávelEnsaio Clínico Duplo-CegoDiabetesEsteatose HepáticaTetraidrocanabivarina (THCV)
  75. 2016

    Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity

  76. 2016

    Efficacy and Safety of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients With Chronic HCV Genotype 1 Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ION Trials

  77. 2016

    Efficacy and safety of nabiximols (Sativex(®)) on multiple sclerosis spasticity in a real-life Italian monocentric study.

  78. 2016

    Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain: A systematic review of randomized controlled studies.

  79. 2016

    Efficacy, tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases (fibromyalgia syndrome, back pain, osteoarthritis, rheumatoid arthritis): A systematic review of randomized controlled trials

    InconclusivoMetanálise ClínicaArtriteArtrite — ReumatoideArtrite — OsteoartriteTHC Farmacêutico+1
  80. 2016

    Efficacy, Tolerability, and Safety of Cannabinoid Treatments in the Rheumatic Diseases: A Systematic Review of Randomized Controlled Trials

  81. 2016

    Efficacy, tolerability, and safety of cannabinoids for chemotherapy-induced nausea and vomiting--a systematic review of systematic reviews.

  82. 2016

    Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review.

  83. 2016

    Endocannabinoid concentrations in hair are associated with PTSD symptom severity.

  84. 2016

    Endocannabinoid Modulation of Orbitostriatal Circuits Gates Habit Formation.

  85. 2016

    Endocannabinoid receptor blockade increases hepatocyte growth factor and reduces insulin levels in obese women with polycystic ovary syndrome

  86. 2016

    Endocannabinoid regulation in white and brown adipose tissue following thermogenic activation

  87. 2016

    Endocannabinoid signaling enhances visual responses through modulation of intracellular chloride levels in retinal ganglion cells.

    FavorávelEstudo em AnimaisCegueira NoturnaAnandamida (AEA)Endocanabinoide (não especificado)+4
  88. 2016

    Endocannabinoid System: A Multi-Facet Therapeutic Target.

  89. 2016

    Endocannabinoids and Stress Resilience: Is Deficiency Sufficient to Promote Vulnerability?

    FavorávelMetanáliseAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+1
  90. 2016

    Endocannabinoids as Guardians of Metastasis

    FavorávelMetanáliseCâncerCâncer — MetastáticoTHC:CBD Farmacêutico
  91. 2016

    Endocannabinoids in the gastrointestinal tract

  92. 2016

    Endocannabinoids in the Gut

  93. 2016

    Endocannabinoids--at the crossroads between the gut microbiota and host metabolism

  94. 2016

    Endocannabionoid System In Neurological Disorders

    FavorávelMetanáliseEsclerose MúltiplaDoença de AlzheimerDoença de Parkinson+1
  95. 2016

    Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease.

  96. 2016

    Enhancement of Anandamide-Mediated Endocannabinoid Signaling Corrects Autism-Related Social Impairment

  97. 2016

    Evaluating Sativex® in Neuropathic Pain Management: A Clinical and Neurophysiological Assessment in Multiple Sclerosis

    FavorávelEnsaio ClínicoDorInflamaçãoDor — CrônicaTHC:CBD Farmacêutico+5
  98. 2016

    Exogenous hepatitis B virus envelope proteins induce endoplasmic reticulum stress: involvement of cannabinoid axis in liver cancer cells

    InconclusivoEstudo LaboratorialCâncerHepatiteCâncer — FígadoCanabinoides Sintéticos AM-x
  99. 2016

    Expectancy mediated effects of marijuana on menopause symptoms

    FavorávelMetanáliseMenopausa
  100. 2016

    Experimental cannabidiol treatment reduces early pancreatic inflammation in type 1 diabetes.

    FavorávelEstudo em AnimaisDiabetes